Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Akros Pharma Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Akros Pharma Inc, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
YOOYOUNG PHARMACEUTICAL CO, LTD Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of YOOYOUNG PHARMACEUTICAL CO, LTD, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
AprilBio Co.,Ltd Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of AprilBio Co.,Ltd, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Veloxis Pharmaceuticals, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Veloxis Pharmaceuticals, Inc, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
AevisBio Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of AevisBio Inc., covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Phanes Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Phanes Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Cyrus Therapeutics Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Cyrus Therapeutics Inc., covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
METiS TechBio Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of METiS TechBio, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Yifan Pharmaceuticals Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Yifan Pharmaceuticals, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
SK Bioscience Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of SK Bioscience, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Precision Biosciences Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Precision Biosciences, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
TG Immunopharma Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of TG Immunopharma, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.